Drugs / Influenza A (H1N1) monovalent vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00992017 | Oct 2009 → Nov 2010 | HIV infectious disease, swine influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Influenza A (H1N1) monovalent vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00992017 ↗ |
| Known as | pH1N1 vaccine | “HIV-infected women 18-39 years of age and 14-34 weeks' gestation on antiretroviral therapy received two 30-μg doses of unadjuvanted, inactivated pH1N1 vaccine 21 days apart.” PMID 23378284 ↗ Feb 2013 |
| Modality | Vaccine | “H1N1 influenza vaccine” NCT00992017 ↗ |
| Route | Intramuscular | “Two 15-microgram intramuscular vaccine injections given together form one dose” NCT00992017 ↗ |